novel parpi arpi therapeutic combinations in 1l mcrpc: findings from clinical trials
Published 8 months ago • 79 plays • Length 4:02Download video MP4
Download video MP3
Similar videos
-
1:37
novel immunotherapeutic approaches under evaluation in patients with mcrpc
-
2:09
current perspectives from clinical trials using parp inhibitors for prostate cancer
-
12:00
hipec: a novel treatment for advanced abdominal cancers
-
3:38
precision medicine in mcrpc
-
51:23
parpi: precision medicine in advanced prostate cancer (2023)
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
35:38
parp inhibitor combination regimens for prostate cancer management
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
1:46
os after progression on first novel hormonal therapy in mcspc vs mcrpc
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
35:58
esmo 2021: parpi data and their role in mono/combination therapies
-
2:30
parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
-
1:39
challenges in the field of parpi treatment for mcrpc
-
42:08
prostate cancer: clinical guidelines, novel therapies, and therapeutic uncertainty
-
1:38
novel combination therapy regimen shows promising results for prostate cancer
-
2:02
unanswered questions regarding the use of parp inhibitors for patients with mcrpc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
0:49
combinations may combat parp resistance
-
38:45
the profound trial - lynparza in hrrm mcrpc